New Delhi, Feb. 13 -- Natco Pharma declared their Q3 results on 12 Feb, 2025, revealing a significant decline in both revenue and profit. The company reported a profit of Rs.133 crore, a decrease of 37.47% year-over-year, while revenue fell to Rs.474.8 crore, down 37.41% compared to the same period last year. Additionally, when compared to the previous quarter, revenue saw a steep decline of 65.37% and profit plummeted by 80.36%.

The company's selling, general, and administrative expenses showed a slight decline of 6.53% quarter-over-quarter; however, they increased by 16.16% year-over-year. This increase in expenses, coupled with the sharp drop in revenue, contributed to the overall decline in profitability.

Operating income was notabl...